Ticker Launch
Sign inTry it free

SPAC · Merger completed

ARYA Sciences Acquisition Corp III

Business combination with Nautilus Biotechnology, Inc.

ARYA Sciences Acquisition Corp III is a blank-check company (SPAC) that raised $130M in its initial public offering on Aug 10, 2020, listing on Nasdaq Capital Market. It completed its business combination with Nautilus Biotechnology, Inc. on Jun 9, 2021; the combined company is Nautilus Biotechnology, Inc. (NAUT). Kirkland & Ellis advised the SPAC and Skadden, Arps advised the underwriters on the IPO.

Nautilus Biotechnology is developing a proteomics platform that aims to deliver greater sensitivity, speed and completeness at lower cost than is currently possible. It is the target of a business combination with ARYA Sciences Acquisition Corp III.

Status
Merger completed
IPO date
Aug 10, 2020
IPO size
$130M
IPO exchange
Nasdaq Capital Market
Target
Nautilus Biotechnology, Inc. (Old Nautilus)
Announced
Feb 8, 2021
Closed
Jun 9, 2021
Combined company
Nautilus Biotechnology, Inc. (NAUT)
SPAC counsel (IPO)
Kirkland & Ellis and Ogier
Underwriters' counsel (IPO)
Skadden, Arps

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2021